Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Chugai Pharmaceutical Co. Ltd.
4519Current price
6 915 JPY
+15.19 JPY (+0.22%)
Last closed
6 980 JPY
Company
www.chugai-pharm.co.jp
ISIN
JP3519400000
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
Tokyo Stock Exchange
Capitalization
11 489 261 831 682 JPY
Yield for 12 month
+56.24 %
1Y
3Y
5Y
10Y
15Y
4519
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, FoundationOne, Polivy, Rozlytrek, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, and Gazyva; Edirol, an Osteoporosis agent; Mircera, an erythropoiesis agent; Oxarol, an agent for secondary hyperparathyroidism; and other diseases comprise Hemlibra, CellCept, Bonviva, Tamiflu, Evrysdi, Ronapreve, Vabysmo, and Enspryng. It has various development product candidates in the areas of oncology, immunology, neuroscience, hematology, ophthalmology, and other diseases. Chugai Pharmaceutical Co., Ltd. has strategic alliances and collaboration with Roche Group. The company was founded in 1925 and is headquartered in Chuo, Japan. Chugai Pharmaceutical Co., Ltd. operates as a subsidiary of Roche Holding Ltd. Address: 2-1-1 Nihonbashi-Muromachi, Chuo, Japan, 103-8324
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
899 786.25 JPYP/E ratio
32.363Dividend Yield
1.17 %Current Year
+1 111 740 683 574 JPY
Last Year
+1 260 369 641 431 JPY
Current Quarter
+316 017 221 188 JPY
Last Quarter
+237 028 671 260 JPY
Current Year
+693 242 015 793 JPY
Last Year
+783 958 507 905 JPY
Current Quarter
+228 047 652 461 JPY
Last Quarter
+164 054 142 712 JPY
Key Figures 4519
1 year
3 years
5 years
10 years
EBITDA
518 273 213 929 JPY
Operating Margin TTM
PE Ratio
32.363
Return On Assets TTM
15.63 %
PEG Ratio
6.2615
Return On Equity TTM
21.75 %
Wall Street Target Price
899 786.25 JPY
Revenue TTM
1 084 934 682 974 JPY
Book Value
1 064.91 JPY
Revenue Per Share TTM
Dividend Share
81.03 JPY
Quarterly Revenue Growth YOY
18.1 %
Dividend Yield
1.17 %
Gross Profit TTM
783 958 507 839 JPY
Earnings per share
213.74 JPY
Diluted Eps TTM
213.74 JPY
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
34.4 %
Profit Margin
32.74 %
Dividend Analytics 4519
Dividend growth over 5 years
433 %Continuous growth
2 yearsPayout Ratio 5 years average
44 %Dividend History 4519
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
82
Ex Dividend Date
27.12.2024
Forward Annual Dividend Yield
1.17 %
Last Split Factor
3:1
Payout Ratio
37.54 %
Last Split Date
29.06.2020
Dividend Date
–
Stock Valuation 4519
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
32.363
Forward PE
29.5858
Enterprise Value Revenue
9.7391
Price Sales TTM
10.5898
Enterprise Value EBITDA
21.6283
Price Book MRQ
6.4957
Financials 4519
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 4519
For 52 weeks
4 174.3 JPY
7 487.52 JPY
50 Day MA
6 717.38 JPY
Shares Short Prior Month
–
200 Day MA
5 793.17 JPY
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart